Why are you looking at Mapp Biopharmaceutical?
Email me when a Mapp Biopharmaceutical recompete window opens.
Capability
Service linesRESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Work mix: 100% prime · 0% sub · primary NAICS 541714 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
2 agenciesRecompete exposure: High · 1 in 24mo
Mapp Biopharmaceutical has an estimated $30.9M in contracts returning to market over the next 24 months.
Agency buyer map
2 buyersRecompete exposure
HighMapp Biopharmaceutical has an estimated $30.9M in contracts returning to market over the next 24 months.
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Mapp Biopharmaceutical hold?
Mapp Biopharmaceutical (UEI M9V9QTHR1H28) shows $72.2M across 13 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Mapp Biopharmaceutical have?
Mapp Biopharmaceutical shows $72.2M across 13 award actions. SCOUT tracks 1 incumbent recompetes ($30.9M) returning to market in the next 24 months.
Which agencies does Mapp Biopharmaceutical work with?
Mapp Biopharmaceutical’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%), Department of Defense (DOD) (0%).
What is the UEI for Mapp Biopharmaceutical?
The Unique Entity ID (UEI) for Mapp Biopharmaceutical is M9V9QTHR1H28.
Does Mapp Biopharmaceutical have contracts coming up for recompete?
Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Mapp Biopharmaceutical, — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.